BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9853759)

  • 1. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.
    Holland SJ; Gale NW; Mbamalu G; Yancopoulos GD; Henkemeyer M; Pawson T
    Nature; 1996 Oct; 383(6602):722-5. PubMed ID: 8878483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.
    Labrador JP; Brambilla R; Klein R
    EMBO J; 1997 Jul; 16(13):3889-97. PubMed ID: 9233799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
    Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
    EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of EphB2-tyrosine kinase receptor and its ligand conveys dorsalization signal in Xenopus laevis development.
    Tanaka M; Wang DY; Kamo T; Igarashi H; Wang Y; Xiang YY; Tanioka F; Naito Y; Sugimura H
    Oncogene; 1998 Sep; 17(12):1509-16. PubMed ID: 9794228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of the olfactory marker protein at 2.3 A resolution.
    Smith PC; Firestein S; Hunt JF
    J Mol Biol; 2002 Jun; 319(3):807-21. PubMed ID: 12054872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elk-L3, a novel transmembrane ligand for the Eph family of receptor tyrosine kinases, expressed in embryonic floor plate, roof plate and hindbrain segments.
    Gale NW; Flenniken A; Compton DC; Jenkins N; Copeland NG; Gilbert DJ; Davis S; Wilkinson DG; Yancopoulos GD
    Oncogene; 1996 Sep; 13(6):1343-52. PubMed ID: 8808709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the ephrin-B1 ectodomain: implications for receptor recognition and signaling.
    Nikolov DB; Li C; Barton WA; Himanen JP
    Biochemistry; 2005 Aug; 44(33):10947-53. PubMed ID: 16101278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eph receptors and ephrins restrict cell intermingling and communication.
    Mellitzer G; Xu Q; Wilkinson DG
    Nature; 1999 Jul; 400(6739):77-81. PubMed ID: 10403252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites.
    Smalla M; Schmieder P; Kelly M; Ter Laak A; Krause G; Ball L; Wahl M; Bork P; Oschkinat H
    Protein Sci; 1999 Oct; 8(10):1954-61. PubMed ID: 10548040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
    Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
    Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ephrin-A1 and ephrin-A4 as ligands for the EphA8 receptor protein tyrosine kinase.
    Choi S; Jeong J; Kim T; Park S
    Mol Cells; 1999 Aug; 9(4):440-5. PubMed ID: 10515610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemometrical classification of ephrin ligands and Eph kinases using GRID/CPCA approach.
    Myshkin E; Wang B
    J Chem Inf Comput Sci; 2003; 43(3):1004-10. PubMed ID: 12767159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH; Zisch AH; Dodelet VC; Pasquale EB
    Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube.
    Bergemann AD; Zhang L; Chiang MK; Brambilla R; Klein R; Flanagan JG
    Oncogene; 1998 Jan; 16(4):471-80. PubMed ID: 9484836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
    Elowe S; Holland SJ; Kulkarni S; Pawson T
    Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor.
    Holmberg J; Clarke DL; Frisén J
    Nature; 2000 Nov; 408(6809):203-6. PubMed ID: 11089974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Eph receptors and ephrins in segmental patterning.
    Xu Q; Mellitzer G; Wilkinson DG
    Philos Trans R Soc Lond B Biol Sci; 2000 Jul; 355(1399):993-1002. PubMed ID: 11128993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.